Antibody-enabled structural biology and AI-driven antibody design

Area of Science:

• Structural biology
• Biochemistry
• Drug discovery

Background:

• Membrane proteins are crucial for cellular functions and represent key therapeutic targets.
• Their structural characterization is difficult due to instability and heterogeneity.
• Antibody-based methods and AI have emerged as powerful tools.

Purpose of the Study:

• To review the impact of antibody engineering on membrane protein structural biology.
• To examine the role of AI in accelerating structure determination and drug design.
• To highlight the synergistic potential of these approaches for therapeutic discovery.

Main Methods:

• Utilizing antibody-based approaches like immunoglobulins, Fabs, nanobodies, and DARPins.
• Applying artificial intelligence and machine learning for predictive modeling and rational design.
• Integrating advanced techniques for cryo-electron microscopy (cryo-EM).

Main Results:

• Antibody engineering stabilizes dynamic membrane protein states and enhances molecular weight for cryo-EM.
• AI accelerates structure determination and guides the design of protein-ligand and antibody-antigen interactions.
• Previously inaccessible membrane protein complexes are now visualized.

Conclusions:

• The combination of antibody engineering and AI is transforming structural biology.
• These integrated approaches are significantly advancing therapeutic discovery for membrane protein targets.
• This synergy offers unprecedented opportunities for understanding and targeting cellular processes.